MedTrace Logo

Evaluation of Quality of Life and Psychosocial Status in Children With Inflammatory Bowel Disease

NCT06270277 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2024-02-22

No results posted yet for this study

Summary

Inflammatory bowel disease (IBD) is a chronic condition that affects the psychosocial status and physical activities of children and their parents in many ways. Our study aimed to investigate the variability of disease-related quality of life and behavioral and emotional adjustment issues compared to a healthy control group among adolescents and their families diagnosed with IBD. Children with IBD and the healthy control group, as well as the parents of both groups, will administered the Pediatric Quality of Life Inventory (PedsQL) and Strengths and Difficulties Questionnaire (SDQ). The PedsQL is a scale used to assess physical and psychosocial functioning based on the individual's own experiences, commonly employed in clinical trials and quality improvement initiatives. The scale evaluates physical activity status and psychosocial functioning through questions related to emotional, social, and school-related issues.

Conditions

  • Inflammatory Bowel Diseases
  • Psychosocial Impairment

Interventions

DIAGNOSTIC_TEST

Pediatric Quality of Life Inventory (PedsQL)

Questionnaire

DIAGNOSTIC_TEST

Strengths and Difficulties Questionnaire (SDQ)

Questionnaire

Sponsors & Collaborators

  • Sisli Hamidiye Etfal Training and Research Hospital

    lead OTHER

Principal Investigators

  • Nafiye Urgancı, M.D. · Sisli Hamidiye Etfal Training and Research Hospital, Division of pediatric gastroenterology

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-14
Primary Completion
2024-02-20
Completion
2024-02-21

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06270277 on ClinicalTrials.gov